Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27902987 | 0.98 | MAPT (0.47) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL7739098 | 0.94 | MAPT (0.52) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL28459246 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL17581568 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL17581577 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL17581550 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL28897821 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL2399762 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL17581552 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL2397886 | 0.92 | MAPT (0.55) | MAPTTSHRCYP3A4ATMTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111647975-A | Novel spandex oil agent and spandex obtained through treatment of novel spandex oil agent | 烟台锐泽化学品有限公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-109456165-A | Pure plant mother liquor solvent extraction system and method | 英威达纺织（英国）有限公司 | 2019-03-12 | — | — | CN | disclosed |
| CN-105164097-A | Pure plant mother liquor solvent extraction system and method | INVISTA TECH SARL | 2015-12-16 | — | — | CN | disclosed |
| US-20150315116-A1 | PURE PLANT MOTHER LIQUOR SOLVENT EXTRACTION SYSTEM AND METHOD | INVISTA NORTH AMERICA S.A.R.L. | 2015-11-05 | — | — | US | disclosed |
| WO-2015157082-A1 | MINIMIZING RECYCLE OF P-TOLUIC ACID WITHIN A PTA PURIFICATION PLANT | INVISTA NORTH AMERICA S.A.R.L. (US) | 2015-10-15 | — | — | WO | disclosed |
| EP-2914571-A1 | PURE PLANT MOTHER LIQUOR SOLVENT EXTRACTION SYSTEM AND METHOD | Invista Technologies S.à.r.l. (CH) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014070766-A1 | PURE PLANT MOTHER LIQUOR SOLVENT EXTRACTION SYSTEM AND METHOD | INVISTA NORTH AMERCIA S.A. R.L. (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20140121406-A1 | PURE PLANT MOTHER LIQUOR SOLVENT EXTRACTION SYSTEM AND METHOD | INVISTA NORTH AMERICA S.A.R.L. (US) | 2014-05-01 | — | — | US | disclosed |
| US-8450319-B2 | Pyrrolopyridazinone compound | UBE INDUSTRIES, LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| EP-1982986-B1 | PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR | UBE INDUSTRIES (JP) | 2012-03-07 | — | — | EP | disclosed |
| US-20090036453-A1 | Pyrrolopyridazinone Compound | UBE INDUSTRIES, LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1982986-A1 | PYRROLOPYRIDAZINONE COMPOUND | Ube Industries, Ltd. (JP) | 2008-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036453-A1 | Pyrrolopyridazinone Compound | CBR3, CBR1, CYC1 | MAPT 4877/4885TSHR 1420/4885CYP3A4 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.